ImmunoGen Inc expected to post earnings of 4  cents a share - Earnings Preview

ImmunoGen

31/10/2023 18:53

* ImmunoGen Inc  IMGN.OQ   IMGN.O  is expected to show a
rise in
quarterly revenue when it reports  results 
    * The Waltham Massachusetts-based  company is expected to
report 
a 592.1% increase in revenue to $106.416 million from $15.38
million a year ago, according to the mean estimate from 12
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for ImmunoGen Inc is
for
earnings of 4 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 12 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for ImmunoGen
Inc is
$24​, above​ its last closing price of $14.04. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.14       -0.14      -0.02     Beat    85.6
 Mar. 31 2023  -0.25       -0.25      -0.16     Beat    35.8
 Dec. 31 2022  -0.29       -0.30      -0.23     Beat    22.5​
 Sep. 30 2022  -0.26       -0.25      -0.31     Missed  -21.8
 ​​Jun.        -0.20       -0.21      -0.24     Missed  -13.2
 30 2022                                                
 Mar. 31 2022  -0.21       -0.21      -0.10     Beat    52.6​
 Dec. 31 2021  -1.63       -1.71      -0.17     Beat    90
 Sep. 30 2021  -0.18       -0.18      -0.18     Met     2.4
 This summary was machine generated October 31 at 18:52 GMT.  All
figures in US dollars  unless otherwise stated